LMC | Manna Research Capabilities Include:
Did you know?
• 19 sites across 4 provinces with 20+ years research experience as operations started in 1996
• >1600 clinical trials conducted
• Comprehensive patient database – >500,000 patients with addition of 50,000 new patients per year
• >1600 clinical trials conducted
• Comprehensive patient database – >500,000 patients with addition of 50,000 new patients per year
• Access to a network of 80 Family Physicians & 75 Specialists with focus in Endocrine Disorders
• Phase I – 12 bed clinical pharmacology unit in Greater Toronto Area (4th largest city in North America)
• Voted one of Canada’s Best Work Places in 2014 & 2015
• Phase I – 12 bed clinical pharmacology unit in Greater Toronto Area (4th largest city in North America)
• Voted one of Canada’s Best Work Places in 2014 & 2015
• Consistent leaders in Canadian & Global enrollment
• Able to work with central Ethics Review Boards
• Able to work with central Ethics Review Boards
LMC Research
Cardiovascular
Chronic Kidney Disease
Diabetes
Lipids
NASH
Obesity
Chronic Kidney Disease
Diabetes
Lipids
NASH
Obesity
Manna Research
Cardiology
Dermatology
Endocrinology
Gastroenterology
Gynecology
Immunology / Infectious Disease – Vaccines
Dermatology
Endocrinology
Gastroenterology
Gynecology
Immunology / Infectious Disease – Vaccines
Musculoskeletal
Psychiatry/Psychology
Pulmonary/Respiratory
Rheumatology
Urology
Women’s & Men’s Health
Psychiatry/Psychology
Pulmonary/Respiratory
Rheumatology
Urology
Women’s & Men’s Health
PHASE I
- 12 Metabolic Beds
- Glucose Clamping
- Metabolic Kitchen
- Access to Primary Care Patients
PHASE II – III
- 19 Sites Across Canada
- 50 Endocrinologists
- Access to 80 GP’s and 75 Specialists with focus in Endocrine Disorders
- Canada’s Largest Diabetes & Obesity Patient Registries
- Comprehensive patient database – >500,000 patients with addition of 50,000 new patients per year
PHASE IV
- Post- Marketing Analysis
- Registry Analysis
- Compliance Programs
Centralized Research Network
- < 2-week Health Canada approvals
- Central Ethics capability
- CTA / Budget with < 5-day average turnaround
- < 2-week Start-Up timelines
- Regulatory Affairs with Start-Up Specialists
- One point of contact – feasibilities@LMCManna.com
Patient-Centric
- COVID-19 Pre-screening prior to visit
- 100% telemedicine & virtual visits capability
- Direct-to-Patient (DTP) care (home visits) as needed
- Full Recruitment & Marketing Team – Call Centre
- E-consent capability
- Patient Advisory Group access
Extended Services
- Full Service CRO support as needed
- Phase 1-4 capabilities
- Local Labs – PBMC available
- Access to COVID testing – viral or immunity
- Quality Management Systems
- Community & Patient Partnerships
Membership & Distinctions
- Part of Sanofi’s “Diabetes Centers of Excellence” Network
- Canadian Association of Independent Clinical Research (CAICR) Membership
- Society for Clinical Research Sites (SCRS) Membership
- PharmaTimes Clinical Research Coordinator of the Year 2017 (CROY 2017)
- Site Patient Recruitment Innovation Award (SPRIA) 2017 Winner
LMC | Manna Research Highlights
- Efficient Start Up – 33 First patient visit (FPFV) entered into trial for Canada since 2013,with 13 FPFV in 2016 alone
- >4000 patient randomizations since 2013 across all sites in Canada
- Global leaders in enrollment – possibility of using one network to enroll entire country patient allocation
- Internal Quality Assurance & Quality Control Program – Successful FDA, Health Canada & Sponsor audits
- Benefits of research in Canada: high quality, speed (30 day regulatory approval), & value (due to exchange rate)